APHA Legal & Regulatory Framework for Pharmacy Immunization 2 — Questions and Answers
Question 1: Which reporting system must pharmacists use to report suspected vaccine adverse events in the United States?
- Vaccine Adverse Event Reporting System (VAERS) (Correct answer)
- MedWatch FDA Safety Reporting Portal
- CDC WONDER database
- National Healthcare Safety Network (NHSN)
Correct answer: Vaccine Adverse Event Reporting System (VAERS)
VAERS is the national pharmacovigilance system co-managed by FDA and CDC where healthcare providers are required to report certain adverse events following vaccination.
Question 2: What is the primary role of a state immunization information system (IIS) for pharmacist immunizers?
- To provide a consolidated patient immunization history and record doses administered by the pharmacist (Correct answer)
- To approve or deny vaccine administration requests from pharmacists
- To store vaccine cold chain temperature logs from pharmacy refrigerators
- To issue standing orders authorizing pharmacist immunization activities
Correct answer: To provide a consolidated patient immunization history and record doses administered by the pharmacist
State IIS databases aggregate immunization records from multiple providers, allowing pharmacists to access a patient's complete vaccine history and record new doses administered.
Question 3: Which federal law expanded pharmacist authority to administer vaccines during the COVID-19 pandemic beyond what state law allowed?
- PREP Act Declaration (Correct answer)
- Omnibus Budget Reconciliation Act (OBRA-90)
- Pharmacy Practice Act amendments
- Affordable Care Act Section 1557
Correct answer: PREP Act Declaration
PREP Act declarations during the COVID-19 pandemic preempted state restrictions and authorized pharmacists and pharmacy interns to administer covered vaccines to eligible populations.
Question 4: A pharmacist discovers a patient was previously compensated through VICP for a vaccine injury. What is the implication for future vaccination?
- VICP compensation does not preclude future vaccination; each dose decision is based on current clinical assessment and contraindications (Correct answer)
- The patient is permanently contraindicated from receiving any vaccine covered by VICP
- The patient must obtain written physician approval before receiving any future vaccination
- The pharmacist must file a VAERS report before administering any future vaccine to this patient
Correct answer: VICP compensation does not preclude future vaccination; each dose decision is based on current clinical assessment and contraindications
Past VICP compensation indicates a prior adverse event but does not automatically contraindicate future vaccines; each vaccination decision requires individualized clinical assessment.
Question 5: What minimum documentation is required after administering a vaccine in a pharmacy setting under federal and most state guidelines?
- Date, vaccine name, lot number, manufacturer, site/route, VIS edition date, and administering pharmacist identity (Correct answer)
- Only the vaccine name and lot number in the patient's medication profile
- A signed consent form and photo ID of the patient
- VAERS report number and IIS confirmation code
Correct answer: Date, vaccine name, lot number, manufacturer, site/route, VIS edition date, and administering pharmacist identity
Federal law and ACIP standards require documentation of date, vaccine name, lot number, manufacturer, dose/route/site, VIS date, and the provider's name and address.
Question 6: Which entity sets the recommended immunization schedules that form the clinical standard of care for pharmacist immunizers in the US?
- Advisory Committee on Immunization Practices (ACIP) (Correct answer)
- American Pharmacists Association (APhA)
- FDA Center for Biologics Evaluation and Research (CBER)
- Joint Commission on Pharmacy Practitioners (JCPP)
Correct answer: Advisory Committee on Immunization Practices (ACIP)
ACIP, a federal advisory committee to the CDC, establishes the recommended immunization schedules for children and adults that represent the standard of care in the US.
Which reporting system must pharmacists use to report suspected vaccine adverse events in the United States?